Kusajili – Clinical trials directory

Result of your search per sponsor: Jan-Willem C Alffenaar, PharmD, PhD

Woman and Man Max 99 years
Jan-Willem C Alffenaar, PharmD, PhD Update Il y a 4 ans

Pharmacokinetics and Safety of Moxifloxacin The main objective of this prospective clinical trial is to compare pharmacokinetics and safety and tolerability of a standard dose (400 mg) with an escalated dose (600 mg; 800 mg) of moxi...

Country Netherlands
organs None
Specialty None

Closed trial

More information